Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
J Insect Physiol ; 126: 104100, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32822690

RESUMEN

The immune system of Rhodnius prolixus comprehends the synthesis of different effectors that modulate the intestinal microbiota population and the life cycle of the parasite Trypanosoma cruzi inside the vector midgut. One of these immune responses is the production of reactive nitrogen species (RNS) derived by the action of nitric oxide synthase (NOS). Therefore, we investigated the effects of L-arginine, the substrate for nitric oxide (NO) production and Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME), an inhibitor of NOS, added in the insect blood meal. We analyzed the impact of these treatments on the immune responses and development of intestinal bacteria and parasites on R. prolixus nymphs. The L-arginine treatment in R. prolixus nymphs induced a higher NOS gene expression in the fat body and increased NO production, but reduced catalase and antimicrobial activities in the midgut. As expected, L-NAME treatment reduced NOS gene expression in the fat body. In addition, L-NAME treatment diminished catalase activity in the hemolymph and posterior midgut reduced phenoloxidase activity in the anterior midgut and increased the antimicrobial activity in the hemolymph. Both treatments caused a reduction in the cultivatable intestinal microbiota, especially in insects treated with L-NAME. However, T. cruzi development in the insect's digestive tract was suppressed after L-arginine treatment and the opposite was observed with L-NAME, which resulted in higher parasite counts. Therefore, we conclude that induction and inhibition of NOS and NO production are associated with other R. prolixus humoral immune responses, such as catalase, phenoloxidase, and antibacterial activities in different insect organs. These alterations reflect on intestinal microbiota and T. cruzi development.


Asunto(s)
Microbioma Gastrointestinal/efectos de los fármacos , Sistema Inmunológico/efectos de los fármacos , Óxido Nítrico , Rhodnius , Trypanosoma cruzi/efectos de los fármacos , Animales , Arginina/antagonistas & inhibidores , Arginina/farmacología , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Tracto Gastrointestinal/efectos de los fármacos , Tracto Gastrointestinal/microbiología , Expresión Génica/efectos de los fármacos , Genes de Insecto , Hemolinfa/efectos de los fármacos , Hemolinfa/inmunología , Hemolinfa/metabolismo , Inmunidad Humoral/efectos de los fármacos , Insectos Vectores/inmunología , Insectos Vectores/microbiología , Insectos Vectores/parasitología , Monofenol Monooxigenasa/efectos de los fármacos , Monofenol Monooxigenasa/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/metabolismo , Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa/metabolismo , Rhodnius/inmunología , Rhodnius/microbiología , Rhodnius/parasitología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda